About
Stem Cell Rejuvenation by Cdc42 Inhibition
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
54
By Phase
PHASE2: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07035860Lead Sponsor
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
N/ANot yet recruiting
34 participants
Started: Jun 16, 2025 · Completed: Jun 15, 2028
NCT06379087Lead Sponsor
Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
PHASE2Recruiting
20 participants
Started: May 1, 2024 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Cincinnati, OH, United States
Map
Loading map...